MedTec owner discusses success of MBST for treating MSK conditions

magnetic resonance therapy

The managing director and owner of MedTec Axel Muntermann was recently interviewed by Wirtschaftsforum, a journal for economic development and finances, on the exciting development of magnetic resonance technology and therapy in the treatment of a wide range of MSK conditions.

Axel describes how he first came across the possibility of using magnetic resonance for therapy purposes.

“Magnetic resonance imaging showed effects that were distinctive but were classified as placebo, for example when patients showed improvements in their running afterwards,” he explains.

He recruited nuclear spin experts from the Max Planck Institute to investigate how MRI technology could be used as an effective treatment. After five years of research, the first device was developed in 2000: “We built a simple therapy device and left out everything that is needed for imaging. Our basic idea was: 20% of the population suffer from joint diseases.

“During decay processes that eventually lead to the artificial joint, cartilage is broken down until the bones rub against each other at some point. For the most part, the doctors can only switch off the pain, but not fix the cause.”

How MBST is used to target arthritis and other degenerative conditions

But that is exactly the aim of MBST magnetic resonance therapy. The therapy seemed successful in clinic usage and the company commissioned studies to evaluate its effectiveness.

“Through cell experiments, we were able to prove that we can use our devices to bring about cell division three times faster than it normally occurs. This is how we stop the disease, trigger regenerative processes and can preserve the natural joint. The pain often disappears during therapy.

Axel concludes: “A cell is a living element with a metabolism. With the software we can control which cell groups – skin, bone, organ or cartilage cells – should be addressed. The procedure is completely harmless.”

To find out if MBST could produce a significant difference to your musculoskeletal condition, call 020 3282 7553 to arrange an assessment.